Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Cabergoline

3

V.a Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

2
Last update : 10/07/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

[Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline].
Archivos de bronconeumologia 2009 Feb;45;100-2 2009 Feb
[Recurrent nerve paralysis and pleural effusion due to cabergoline].
Revista de neurologia 2008 Mar 16-31;46;382-3 2008 Mar 16-31
Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease.
European journal of internal medicine 2005 Apr;16;129-131 2005 Apr

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies